HOME >> BIOLOGY >> NEWS
Final Alert: 16th EORTC NCI AACR Symposium

There are now only three weeks to go to this joint European Organisation for Research and Treatment of Cancer, US National Cancer Institute and American Association for Cancer Research conference.

It offers:

  • First-time public presentations on new cancer drug research and development from experts in Europe, North America, Asia and Australia.
  • Free registration to bona fide media with official press credentials
  • Media centre with free computing, fax, international phone and internet facilities
  • Two news briefings [12.30 hrs CET: Wednesday 29 September & Thursday 30 September]

Topics at the news briefing or to be press-released include:

  • Results from Phase I study of first second-generation antisense cancer drug used in patients
  • Trial shows which brain cancer patients benefit from temozolomide genetic predictive test clears way to targeted treatment
  • New study indicates arsenic could be suitable first-line treatment for a type of leukaemia
  • Prize-winning study shows Glivec effective in yet another type of cancer
  • A revolutionary approach to anti-angiogenesis researchers find way to exploit tumour blood vessels
  • New cell death-inducing monoclonal antibody results from early study targeting TRAIL R2 protein
  • Lypcopene and vitamin E inhibits prostate tumours new laboratory results underpin epidemiological evidence patient trial now started
  • International trial finds acne-type side effect predicts effectiveness of new targeted treatment
  • Laboratory tests show gossypol abandoned as a contraceptive can sensitise prostate cancer to radiotherapy patient trials now planned

Please note: information above on news briefing & press release topics is for information only and is embargoed until the time of the news briefings or press releases.

The conference is an opportunity for the media to listen and talk to some of the 2,000 European, A
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
8-Sep-2004


Page: 1 2

Related biology news :

1. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
2. Final of the 2003/04 Research Councils Business Plan Competition
3. Final results of the two Zevalin pivotal trials in radioimmunotherapy for B cell Non-Hodgkins Lymphoma announced by IDEC Pharmaceuticals
4. L.A.Times Book Prize Finalist: Book On Evolution Of Bird Flight
5. Could A Nasal Vaccine Finally Get Rid Of The Black Death?
6. Last Comment Sought On Agents Proposed For Report On Carcinogens; A Final ForData On Saccharin, And A Re-Review Of Dioxin Announced
7. USGS Issues Wildlife Health Alert: Associates Virus With Salamander Die-Offs
8. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
9. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10. 16th EORTC NCI AACR Symposium
11. Clock cells, tumor suicide, tailored therapies among subjects of AACR-NCI-EORTC Conference

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2019)... ... July 24, 2019 , ... ... PhD, a quality assurance expert with more than 20 years of experience working ... products, has joined the firm as an Expert Consultant. , Dr. Hartzfeld has ...
(Date:7/23/2019)... ... , ... NanoFUSE is pleased to announce the ... spine and orthopedic use. Bioactive glass is a calcium phosphate coated silica that ... orthopedics for over 30 years and now NanoFUSE Biologics has used advanced research ...
(Date:7/19/2019)... ... July 19, 2019 , ... ... Amorphous and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. ... along with Chris Benmore of Argonne National Laboratory and Gabriel de Araujo of ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 05, 2019 , ... ... has been recognized as a distinguished leader by PharmaVOICE magazine, earning him a ... article in the magazine’s July/August special issue. , As the executive vice president ...
(Date:7/26/2019)... (PRWEB) , ... July 25, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston BD ... Waterfront Hotel. As part of Biotech Week Boston , the event provides ...
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought ... certain trait can be removed, replaced, or edited, but Yiping Qi, assistant professor in ... these traditional applications in his latest publication in Nature Plants. In this comprehensive review, ...
(Date:7/9/2019)... ... 08, 2019 , ... Today, at the BIO World Congress on ... (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were ... corn to produce biobased materials. , “Corn is a sustainable, abundant and affordable ...
Breaking Biology Technology:
Cached News: